| |
|
|
|
|
|
|
|||
|
Blood, 1 July 2006, Vol. 108, No. 1, pp. 116-122. Prepublished online as a Blood First Edition Paper on December 8, 2005; DOI 10.1182/blood-2005-06-2245.
Submitted June 6, 2005
Laboratory of Molecular Genetics of Stem Cells, Institute for Research in Immunology and Cancer (IRIC), Montreal, Quebec, Canada * Corresponding author; email: guy.sauvageau{at}umontreal.ca.
Overexpression of Hoxb4 in bone marrow cells promotes expansion of hematopoietic stem cell populations in vivo and in vitro, indicating that this homeoprotein can activate the genetic program which determines self-renewal. However, this function cannot be solely attributed to Hoxb4, since Hoxb4-/- mice are viable and have apparently normal HSC pools. Q-PCR analysis showed that Hoxb4-/- c-Kit+ fetal liver cells expressed moderately higher levels of several Hoxb cluster genes than control cells, raising the possibility that normal HSC activity in Hoxb4-/- mice is due to a compensatory upregulation of other Hoxb genes. In this study, we investigated the competitive repopulation potential of HSCs lacking Hoxb4 alone, or in conjunction with eight other Hoxb genes. Our results show that Hoxb4-/- and Hoxb1-b9-/- fetal liver cells retain full competitive repopulation potential, and the ability to regenerate all myeloid and lymphoid lineages examined. Quantitative Hox gene expression profiling in purified c-Kit+ Hoxb1-b9-/- fetal liver cells revealed an interaction between the Hoxa, b and c clusters with variation in expression levels of Hoxa4, -a11 and -c4. Together, these studies show a complex network of genetic interactions between several Hox genes in primitive hematopoietic cells and demonstrate that HSCs lacking up to 30% of the active Hox genes remain fully competent.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||